Barry R. Davis
Journal of the American Medical Association (JAMA) · 2000–2021
A researcher in the Science corpus: 5 papers; trusts 0 researchers and is trusted by 5 researchers here, as inferred from the citation graph.
Who trusts Barry R. Davis overall
Papers from Barry R. Davis's perspective
Ordered by how strongly the researchers Barry R. Davis trusts endorse each paper. Same corpus, a different order for every researcher.
- Group Sequential Methods with Applications to Clinical Trials
- The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. (Journal of the American Medical Association (JAMA))
- Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate (Annals of Internal Medicine)
- Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention… (Circulation)
- Age affects outcomes in chronic kidney disease. (Journal of the American Society of Nephrology)
- The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. (Kidney International)
- Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. (Journal of the American Medical Association (JAMA))
- Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease (Nature Reviews Nephrology)
- Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. (AJP - Renal Physiology)
- Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). (Circulation)
Their papers
- Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis (2021) — 619 citations
- Relation Between Red Blood Cell Distribution Width and Cardiovascular Event Rate in People With Coronary Disease (2008) — 844 citations
- Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). (2002) — 1,306 citations
- Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). (2002) — 5,360 citations
- Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT) (2000) — 1,369 citations